Innovative NeuroTechnologies, Inc. (INT) is a discovery-stage biotechnology company that seeks diagnostic and therapeutic solutions to major human central nervous system (CNS) disorders, particularly in the area of neurodegeneration. The Company focuses its efforts on such diseases
– Alzheimer’s Disease (AD),
– Parkinson’s Disease (PD),
– Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease),
– Huntington’s Disease (HD),
– Stroke, and
– Multiple Sclerosis (MS).
Innovative NeuroTechnologies, Inc. (INT) is a discovery-stage biotechnology company that seeks diagnostic and therapeutic solutions to major human central nervous system (CNS) disorders, particularly in the area of neurodegeneration. The Company focuses its efforts on such diseases
– Alzheimer’s Disease (AD),
– Parkinson’s Disease (PD),
– Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease),
– Huntington’s Disease (HD),
– Stroke, and
– Multiple Sclerosis (MS).
These are typically fatal neurodegenerative disorders that are currently untreatable and share many characteristics, which make them particularly amenable to INT’s expertise and employed technologies.
